Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: Implications for cancer therapy

Kalia Vijay K, Prabhakara S, Narayanan Vidya

Year : 2009| Volume: 5| Issue : 9 | Page no: 57-60

   This article has been cited by
1 Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
Jermaine Coward,Angus Harding
Frontiers in Oncology. 2014; 4
[Pubmed]  [Google Scholar] [DOI]
2 Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors
Prudence Donovan,Kathleen Cato,Roxane Legaie,Rumal Jayalath,Gemma Olsson,Bruce Hall,Sarah Olson,Samuel Boros,Brent A. Reynolds,Angus Harding
Molecular BioSystems. 2014; 10(4): 741
[Pubmed]  [Google Scholar] [DOI]
3 Is Cancer a Metabolic Disease?
Hilary A. Coller
The American Journal of Pathology. 2013;
[Pubmed]  [Google Scholar] [DOI]
4 Enhanced Radiosensitivity and Chemosensitivity of Breast Cancer Cells by 2-Deoxy-D-Glucose in Combination Therapy
Fahimeh Aghaee,Jalil Pirayesh Islamian,Behzaad Baradaran
Journal of Breast Cancer. 2012; 15(2): 141
[Pubmed]  [Google Scholar] [DOI]
5 Non-cytotoxic radiosensitizers in brain radiotherapy: Journey till the first decade of this millennium
Mohindra, P., Sinha, R.N., Andrews, R.J., Khuntia, D.
Current Cancer Drug Targets. 2012; 12(3): 260-278
[Pubmed]  [Google Scholar]
6 Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response
Richardson, E., Stockwell, S.R., Li, H., Aherne, W., Cuomo, M.E., Mittnacht, S.
PLoS ONE. 2012; 7(2): art-e31627
[Pubmed]  [Google Scholar]


Read this article